Humacyte Inc (HUMA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Sales | 0 | 0 | 31 | 1,301 | 233 |
| Gross Profit | N/A | 0 | 31 | 1,301 | 233 |
| Operating Expenses | 22,512 | 20,790 | 23,525 | 19,832 | 21,996 |
| Operating Income | -22,512 | -20,790 | -23,494 | -18,531 | -21,763 |
| Interest Expense | 1,699 | 1,639 | 1,641 | 1,488 | 1,432 |
| Other Income | -12,758 | 18,709 | -146 | 56,887 | 3,363 |
| Pre-tax Income | -36,969 | -3,720 | -25,281 | 36,868 | -19,832 |
| Net Income Continuous | -36,969 | -3,720 | -25,281 | 36,868 | -19,832 |
| Net Income | $-36,969 | $-3,720 | $-25,281 | $36,868 | $-19,832 |
| EPS Basic Total Ops | -0.36 | -0.04 | -0.25 | 0.36 | -0.19 |
| EPS Basic Continuous Ops | -0.36 | -0.04 | -0.25 | 0.36 | -0.19 |
| EPS Diluted Total Ops | -0.36 | -0.03 | -0.25 | 0.35 | -0.19 |
| EPS Diluted Continuous Ops | -0.36 | -0.03 | -0.25 | 0.35 | -0.19 |
| EBITDA(a) | $-20,079 | $-18,341 | $-21,019 | $-16,117 | $-19,345 |